Degtiar Rose 2023 - Generalizability and Transportability Review - Overview

Summary

Degtiar and Rose give a potential-outcomes-based framework for external validity bias: define the target population and the population average treatment effect (PATE), state the identifying assumptions (internal validity plus external validity), quantify how far study and target populations differ and whether effects are heterogeneous, and then apply a weighting/matching, outcome-regression or doubly robust estimator to move the study estimate to the target. The review also covers methods that combine randomized and observational data and those requiring only summary-level data. The core message: internal validity of an RCT is not enough; both internal and external validity are needed for unbiased effects in a target population.

Overview

Research question. How can causal effect estimates from a study (randomized or observational) be generalized (study population is a subset of the target) or transported (study population is at least partly external to the target) to a target population when effect modifiers have different distributions?

Why a review. Prior reviews were narrower: only RCT-to-target (Stuart et al.; Kern et al.; Tipton and Olsen; Ackerman et al.), identifiability but not estimation (Bareinboim and Pearl 2016), summary-level meta-analysis (Verde and Ohmann; Kaizar), or combining randomized and observational data with a simulation study (Colnet et al. 2020). This paper covers the full range of methods across statistics, epidemiology, computer science and economics, techniques for evaluating generalizability, and recommendations. Reporting guidelines (CONSORT, RECORD, STROBE) recognize the importance of describing generalizability but give no tests or estimation procedures.

Framework (Fig. 2). Estimand Assumptions Evaluating generalizability (is there effect modification? do modifiers differ in distribution?) Generalizability and transportability methods.

Headline decomposition. If the focus is subject-characteristic differences, external validity bias arises solely from (1) variation in the probability of enrollment in the study, (2) heterogeneity in treatment effects, and (3) the correlation between (1) and (2) (Olsen et al. 2013).

Main Content

Source Map

Paper sectionPDF pagesContentCovered in
Abstract; 1. Background1-4target/study/analysis populations (Fig. 1), generalizability vs transportability, internal vs external validity, four sources of external-validity bias, design solutions, framework (Fig. 2), literature gapDegtiar 2023 - Populations, Estimands and External Validity Bias
2. Estimand5-6notation, PATE , SATE , PCATE , PATT, Fig. 3Degtiar 2023 - Populations, Estimands and External Validity Bias
3.1-3.2 Assumptions6-7internal validity (exchangeability, positivity, SUTVA); external validity (selection exchangeability, selection positivity, SUTVA for selection)Degtiar 2023 - Identifying Assumptions
3.3 Transportability7-8modifications for transport; SEM/graphical counterpartDegtiar 2023 - Identifying Assumptions
4.1 Dissimilarity: baseline characteristics8-9SMD, generalization score, generalizability index, covariate-shift classifierDegtiar 2023 - Assessing Dissimilarity Between Study and Target
4.2 Dissimilarity: outcomes9-10outcome comparisons, equivalence tests, sensitivity analysisDegtiar 2023 - Assessing Dissimilarity Between Study and Target
4.3 Testing for treatment effect heterogeneity; failing generalizability10-12subgroup tests, data-driven subgroup discovery, global tests, paths forwardDegtiar 2023 - Testing Treatment Effect Heterogeneity
5 intro; 5.1 Weighting and matching12-16matching, post-stratification, IPPW, odds weights, propensity strataDegtiar 2023 - Weighting and Matching Methods
5.2 Outcome regression16-18OLS, BART, meta-analytic and Bayesian synthesis, hierarchical Bayesian evidence synthesisDegtiar 2023 - Outcome Regression Methods
5.3 Combined propensity and outcome regression18-21TMLE, A-IPPW, calibration, domain adaptation, cross-design synthesis, calibrated risk-adjusted regressionDegtiar 2023 - Doubly Robust and Combined Methods
6. Discussion21-23recommendations, code release, conclusionDegtiar 2023 - Recommendations, Summary-Level Methods and Comparison Tables
Appendix30summary-level-data-only methodsDegtiar 2023 - Recommendations, Summary-Level Methods and Comparison Tables
Acknowledgments, References23-29funding, reference listcited inline
(added) marketing worked examplen/asimulated geo-test transport with four estimatorsDegtiar 2023 - Marketing Application Transporting Experiment Results

Key vocabulary at a glance

TermMeaning in the paper
Generalizabilitystudy population is a subset of the target population
Transportabilitystudy population is at least partly external to the target
Internal validityestimate unbiased for the effect in the population the sample simple-randomly represents (vertical move in Fig. 1)
External validitythe internally valid estimate is unbiased for the effect in a different setting (lateral move in Fig. 1)
PATE / SATE / PCATEpopulation / sample / conditional average treatment effect
IPPWinverse probability of participation weighting (Horvitz-Thompson-like)
A-IPPWaugmented IPPW (doubly robust)

Examples

Illustration used by the authors: a cancer RCT with no African American participants. The target sample is the clinic’s patients; the study sample is the trial’s enrollees; the study population is the hypothetical population those enrollees represent (which includes no African Americans). Dropout of patients with severe adverse events creates an analysis sample of those without severe side effects. A physician applying the trial to their patients is moving laterally in Fig. 1 and incurs external validity bias; Chen and Wong (2018) show African Americans are widely underrepresented in cancer RCTs.

Connections

See Also